These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 28447789)
1. Exploring the Role of N Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789 [TBL] [Abstract][Full Text] [Related]
2. Substituted 4-phenylthiazoles: Development of potent and selective A Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082 [TBL] [Abstract][Full Text] [Related]
3. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637 [TBL] [Abstract][Full Text] [Related]
4. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884 [TBL] [Abstract][Full Text] [Related]
5. Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Alnouri MW; Jepards S; Casari A; Schiedel AC; Hinz S; Müller CE Purinergic Signal; 2015 Sep; 11(3):389-407. PubMed ID: 26126429 [TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related]
7. 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. Gao ZG; Mamedova LK; Chen P; Jacobson KA Biochem Pharmacol; 2004 Nov; 68(10):1985-93. PubMed ID: 15476669 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of DPTN and other selective A Gao ZG; Suresh RR; Jacobson KA Purinergic Signal; 2021 Dec; 17(4):737-746. PubMed ID: 34713378 [TBL] [Abstract][Full Text] [Related]
9. 2-Amino[1,2,4]triazolo[1,5-c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure-Activity Relationships of Potent Adenosine Receptor Antagonists. Burbiel JC; Ghattas W; Küppers P; Köse M; Lacher S; Herzner AM; Kombu RS; Akkinepally RR; Hockemeyer J; Müller CE ChemMedChem; 2016 Oct; 11(20):2272-2286. PubMed ID: 27531666 [TBL] [Abstract][Full Text] [Related]
10. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists. Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271 [TBL] [Abstract][Full Text] [Related]
11. Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Auchampach JA; Jin X; Wan TC; Caughey GH; Linden J Mol Pharmacol; 1997 Nov; 52(5):846-60. PubMed ID: 9351976 [TBL] [Abstract][Full Text] [Related]
12. A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists. Venkatesan G; Paira P; Cheong SL; Federico S; Klotz KN; Spalluto G; Pastorin G Eur J Med Chem; 2015 Mar; 92():784-98. PubMed ID: 25633494 [TBL] [Abstract][Full Text] [Related]
13. Hypothermia in mouse is caused by adenosine A Carlin JL; Jain S; Gizewski E; Wan TC; Tosh DK; Xiao C; Auchampach JA; Jacobson KA; Gavrilova O; Reitman ML Neuropharmacology; 2017 Mar; 114():101-113. PubMed ID: 27914963 [TBL] [Abstract][Full Text] [Related]
14. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A Poli D; Falsini M; Varano F; Betti M; Varani K; Vincenzi F; Pugliese AM; Pedata F; Dal Ben D; Thomas A; Palchetti I; Bettazzi F; Catarzi D; Colotta V Eur J Med Chem; 2017 Jan; 125():611-628. PubMed ID: 27721147 [TBL] [Abstract][Full Text] [Related]
15. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926 [TBL] [Abstract][Full Text] [Related]
16. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. Analysis of a chimeric A1-A3 adenosine receptor. Palmer TM; Benovic JL; Stiles GL J Biol Chem; 1996 Jun; 271(25):15272-8. PubMed ID: 8663009 [TBL] [Abstract][Full Text] [Related]
18. Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists. Olah ME; Jacobson KA; Stiles GL J Biol Chem; 1994 Jul; 269(27):18016-20. PubMed ID: 8027060 [TBL] [Abstract][Full Text] [Related]
19. Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms. Jespers W; Schiedel AC; Heitman LH; Cooke RM; Kleene L; van Westen GJP; Gloriam DE; Müller CE; Sotelo E; Gutiérrez-de-Terán H Trends Pharmacol Sci; 2018 Jan; 39(1):75-89. PubMed ID: 29203139 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: potent and selective adenosine A3 receptor antagonists. Banda V; Chandrasekaran B; Köse M; Vielmuth C; Müller CE; Chavva K; Gautham SK; Pillalamarri S; Mylavaram R; Akkinepally R; Pamulaparthy S; Banda N Arch Pharm (Weinheim); 2013 Oct; 346(10):699-707. PubMed ID: 23996524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]